VeriMomdea-lauraminopropionate hamilelikte güvenli mi?
No harmonised reproductive classification or SCCS/CIR safety assessment specific to DEA‑lauraminopropionate was found; CIR/industry documents treat DEA‑type ingredients as a class of interest but do not assign a reproductive hazard to this specific salt. However, diethanolamine (DEA) itself has shown developmental/neurodevelopmental effects in animal studies (mouse dermal study), so a theoretical mechanism exists via the DEA moiety (choline/metabolic interference) though no direct reproductive data for this specific INCI were located. (Sources: CIR mentions DEA family; animal study: Dose‑response dermal DEA mouse study.)
Related ingredients
Frequently asked questions
- dea-lauraminopropionate hamilelikte güvenli mi?
- No harmonised reproductive classification or SCCS/CIR safety assessment specific to DEA‑lauraminopropionate was found; CIR/industry documents treat DEA‑type ingredients as a class of interest but do not assign a reproductive hazard to this specific salt. However, diethanolamine (DEA) itself has shown developmental/neurodevelopmental effects in animal studies (mouse dermal study), so a theoretical mechanism exists via the DEA moiety (choline/metabolic interference) though no direct reproductive data for this specific INCI were located. (Sources: CIR mentions DEA family; animal study: Dose‑response dermal DEA mouse study.)
- dea-lauraminopropionate emzirirken güvenli mi?
- No data indicate DEA‑lauraminopropionate is classified as a reproductive or lactation hazard; breastfeeding risk would be driven by maternal systemic absorption of DEA moiety, for which no human milk transfer data were identified. Theoretical mechanistic concern derives from DEA animal data, but there is no product‑specific evidence showing transfer into breast milk. (Sources: CIR / DEA literature; PubMed animal study.)
- dea-lauraminopropionate bebek cildi için güvenli mi?
- There are no infant‑specific toxicity or classification data for DEA‑lauraminopropionate. Following conservative exposure considerations, measurable dermal absorption in adults (low) is expected to be higher in infants because of immature skin and higher surface‑area‑to‑body‑weight, so exposure score is increased by +1; hazard remains based on absence of direct evidence for this compound and reliance on theoretical concern from the DEA moiety. (Sources: regulatory INCI listings; DEA animal data.)
- VeriMom dea-lauraminopropionate nasıl puanlıyor?
- VeriMom dea-lauraminopropionate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 87/100 (düşük risk) olarak puanlar.
- Hamilelikte dea-lauraminopropionate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.